RARB and lung cancer: According to the depicted representative data from previous studies, RARB expression is thought to be associated with cellular sensitivity to retinoid in numerous cancer cells, including HNSCC cells, breast cancer cells, lymphocytic leukemia, and lung cancer cells [53–57].